You can buy or sell Nkarta and other stocks, options, and ETFs commission-free!
Nkarta, Inc. Common Stock, also called Nkarta, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA. The listed name for NKTX is Nkarta, Inc. Common Stock.
Paul J. Hastings
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected Mar 15, After Hours